Activery The amorphization specialist
Activery believes that amorphous drugs provide new and innovative routes to final dosage forms with differentiated pharmacokinetics
| Solid state development |
 |
 |
 |
Capabilities and ServicesActivery is offering a thermal analysis service for solid-state elucidation of organic or inorganic compounds. Compounds related to the chemical, polymer, cosmetics or pharmaceutical industry can be investigated. State-of-the-art instrumentation in form of a Modulated DSC and Modulated TGA is available. Unique knowladge on amorphous solids and amorphizationActivery specializes in the production of amorphous formulations of micro- or nanoparticles and possesses a unique knowledge base about amorphous solids, their analysis, characterization and formulation. Our product development team has broad experience generating amorphous drug composites for a variety of drug types. Our expertise will ensure that a solution to your product problem will be found. Activery´s knowledge base will ensure a solution for your solid-state problem. |
Pharma Notes
- New study on Inhaled Drug Delivery Market
- Particles that deliver larger and more effective doses of drugs to cancers
- The global protein therapeutics market will be worth $77bn by 2011 with biogenerics playing an increasingly important rol
- A federal jury in Texas Monday upheld the patent on Johnson & Johnson's arthritis treatment Remicade and ordered Abbott Laboratories to pay its rival $1.67 billion for infringing on the patent
- Transdermal delivery represents an attractive alternative to oral delivery of drugs and is poised to provide an alternative to hypodermic injection tool
Differentiated Generics
- Teva may lose patent challenge
- Labopharm receives notice of ANDA submission with paragraph IV certification for generic of Ryzolt
- Depomed (DEPO) Receives Paragraph IV Notice from Lupin Limited Over Patent Filing for Generic Glumetza Tablets
- The rate and number of successful Paragraph IV challenges is reducing the average effective patent life for innovator drugs
- Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE
Nanoparticles world
- Nanoparticle created to attack cardiovascular plaque
- Nanoparticle lung threat blocked
- Newly-developed nanoparticle to build therapies for treating individuals with cardiovascular disease.
- Nanoparticle Processing in the Solid State Dramatically Increases the Cell Membrane Permeation of a Cholesterol-Lowering Drug, Probucol
- Erectile dysfunction could be treated by a nanoparticle formulation applied directly to the penis